| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3817870
Max Phase: Preclinical
Molecular Formula: C16H19Cl2NO2
Molecular Weight: 328.24
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCCCN1C(=O)C=C(Cl)C1(O)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C16H19Cl2NO2/c1-2-3-4-5-10-19-15(20)11-14(18)16(19,21)12-6-8-13(17)9-7-12/h6-9,11,21H,2-5,10H2,1H3
Standard InChI Key: CMQFCGJPWXRANA-UHFFFAOYSA-N
Associated Targets(non-human)
Cholecystokinin A receptor 1695 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 328.24 | Molecular Weight (Monoisotopic): 327.0793 | AlogP: 4.03 | #Rotatable Bonds: 6 |
| Polar Surface Area: 40.54 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.09 | CX Basic pKa: | CX LogP: 4.45 | CX LogD: 4.45 |
| Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.80 | Np Likeness Score: 0.00 |
References
| 1. Lattmann E, Russell ST, Schwalbe CH, Shortt A, Balaram PN, Theochari E, Alharbi M, Narayanan R, Lattmann P. (2016) Cholecystokinin-1 receptor antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents, 7 (6): [10.1039/C6MD00052E] |
Source
Source(1):